Skip to main content

Closed

ILMN: Illumina, Inc. Stock Analysis | finqOS

Healthcare · Medical - Diagnostics & Research

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth-2.9% / yr

Operating margin21.0%

ROIC13.7%

Financially safe

Strong

Debt / equity0.86×

Interest coverage12.6×

Current ratio1.80×

Valuation

Unrated

P/E ratio37.9×

Illumina, Inc.

ILMNNASDAQ Global Select·USD·Closed

Illumina, Inc.

ILMNNASDAQ·USD·Closed

$205.10

+0.00%

$205.10

+$0.01 (0.00%)

52W Range

99thpctl

Volume

2.16×avg

Mkt Cap

31.03BUSD

P/E

37.9TTM

Div Yield

–ann

52W Range

99thpctl

Volume

2.16×avg

Market Cap

31.03BUSD

P/E Ratio

37.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings